Why active packaging plays such an important role in the Pharmaceutical industry
When it comes to pharmaceutical and healthcare products, many of which are subject to stringent regulatory laws, manufacturers and suppliers must be meticulous when it comes to packaging. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 7, 2020 Category: Pharmaceuticals Source Type: news

‘Significant movement' on Russia's request for phase-3 trial, manufacture of Sputnik V in India
Dr V K Paul, Member (Health) Niti Aayog, who also chairs the national expert group on COVID-19 vaccine administration, said that Indian scientists have looked at the data on Sputnik V, which is in the public domain now, and there would be a need for the phase -3 trial. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 7, 2020 Category: Pharmaceuticals Source Type: news

Activated form of vitamin D reduced severity of Covid infection: Study in Spain
According to the study published in ScienceDirect, 50 of 76 patients hospitalised with Covid-19 were treated with calcifediol and only one required to be admitted in ICU. All were discharged without complications. Of the remainder who did not receive the drug, 13 patients were admitted in ICU and two died. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 7, 2020 Category: Pharmaceuticals Source Type: news

Alembic Pharma arm gets tentative USFDA nod for drug to treat pulmonary arterial hypertension
Alembic Global Holdings SA has received tentative approval from the US Food and Drug Administration for its abbreviated new drug application (ANDA) Treprostinil Injection in the strengths of 20 mg/20 ml (1 mg/ml), 50 mg/20 ml (2.5 mg/ml), 100 mg/20 ml (5 mg/ml), and 200 mg/20 ml (10 mg/ml), multiple-dose vials, Alembic Pharmaceuticals said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 6, 2020 Category: Pharmaceuticals Source Type: news

Hamdard Labs to start clinical trial of two immunity boosting drugs for COVID-19
The company has received all the regulatory approvals to begin the proof of concept clinical trial for its Infuza and Kulzam drugs, Hamdard Laboratories said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 6, 2020 Category: Pharmaceuticals Source Type: news

BDR Pharma to launch 400mg Favipiravir tablets for treating coronavirus patients in India
The company had received approval from the Drugs Controller General of India (DCGI) to manufacture Favipiravir to treat patients with mild to moderate COVID-19 symptoms under the brand name BDFAVI, according to the statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 3, 2020 Category: Pharmaceuticals Source Type: news

India imposes anti-dumping duty on imports of Ciprofloxacin Hydrochloride from China
The department of revenue issued a notification to the effect on September 2, imposing a duty ranging between $0.94 and $3.29 per kg coming from China. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 2, 2020 Category: Pharmaceuticals Source Type: news

The frontrunners in Covid vaccine race will face their moment of truth this month itself
Each of these experimental vaccines has already shown promise in smaller trials designed to flag any serious safety concerns and show whether candidates can spur some response from the immune system. Early safety data is key; unlike drugs, vaccines are typically given to relatively healthy people and shouldn ’t create severe risks. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 2, 2020 Category: Pharmaceuticals Source Type: news

India considers allowing import of raw material for manufacturing crude heparin
Heparin and its related derivative, the low molecular weight heparin, also known as enoxaparin, is an anticoagulant that has demonstrated its effectiveness in treatment of patients infected with Covid-19 virus during the ongoing pandemic. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 2, 2020 Category: Pharmaceuticals Source Type: news

Sanofi and GSK launch trial for COVID-19 protein-based vaccine
Sanofi and GSK said in a joint statement on Thursday they had started the "Phase 1/2" trial for their adjuvanted COVID-19 vaccine, which they hope to make available across the world. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 2, 2020 Category: Pharmaceuticals Source Type: news

Zydus Cadila gets USFDA nod for orthostatic hypotension drug
The drug is used for certain patients who have symptoms of low blood pressure when standing. This condition is also known as orthostatic hypotension. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 2, 2020 Category: Pharmaceuticals Source Type: news

Dr Reddy's launches generic attention deficit disorder drug in US market
New Delhi, Sep 3 () Dr Reddy's Laboratories on Thursday said it has launched Methylphenidate Hydrochloride extended-release tablets, used to treat attention deficit disorder (ADD), in the US market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 2, 2020 Category: Pharmaceuticals Source Type: news

Dr Reddy's launches generic ADD drug in US market
The company's product is generic version of Janssen Pharmaceuticals' Concerta tablets, Dr Reddy's Laboratories said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 2, 2020 Category: Pharmaceuticals Source Type: news

Jubilant Life Sciences seeks nod to roll out Remdesivir tablet
According to the proposal, the company is exploring the possibility of launching 20 mg sublingual tablets. Sublingual administration involves placing a drug under the tongue so that it gets dissolved and absorbed into the blood through the tissues. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 31, 2020 Category: Pharmaceuticals Source Type: news

Biocon Biologics launches Semglee, drug to control high blood sugar, in US
To encourage broad patient access to this important medicine, Mylan is offering Semglee at a wholesale acquisition cost (WAC)[1] of $147.98 per package of five (5) 3ml pens and $98.65 per 10ml vial, representing the lowest WAC for any long-acting insulin glargine on the market, said Biocon in a press release. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 30, 2020 Category: Pharmaceuticals Source Type: news

Pharma sector needs global collaboration: Industry leaders, government officials
Ahead of the 14th edition of the annual BioPharma and Healthcare Summit, that bring stakeholders from India and the United States on one platform, officials and industry leaders said the global health crisis requires a global solution, which can be achieved through global collaboration. India and the United States can play a lead role in this, they said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 30, 2020 Category: Pharmaceuticals Source Type: news

USFDA 'closes' warning letter for three sites of Dr Reddy's Laboratories
Drug firm Dr Reddy's Laboratories on Friday said the US health regulator Food has "closed" warning letter issued for three of its sites in Andhra Pradesh and Telangana, following evaluation of corrective actions taken by the company. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 27, 2020 Category: Pharmaceuticals Source Type: news

US-based BCM ties up with India's BE for COVID-19 vaccine production
In the race to find a cure for the coronavirus infection, Texas-based Baylor College of Medicine (BCM) has entered into a licensing agreement with Indian pharmaceutical company Biological E Limited (BE) for the development of a safe, effective and affordable vaccine. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 27, 2020 Category: Pharmaceuticals Source Type: news

Bangladesh ’s top pharma group & Serum Institute of India join hands for Covid-19 vaccine
The investment amount will be treated as an advance and once the vaccine receives regulatory approvals, SII will include Bangladesh among the countries who will be the first to receive an agreed quantity of this vaccine from SII on a priority basis, according to a press release. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 27, 2020 Category: Pharmaceuticals Source Type: news

India may get COVID-19 vaccine by early 2021, says Bernstein Research
While the vaccine could be available at USD 3-6 (Rs 225 to Rs 550) per dose, herd immunity might be two years away due to implementation challenges, the brokerage said, adding the experience in large scale adult vaccination programmes is thin. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 27, 2020 Category: Pharmaceuticals Source Type: news

Pharmaceutical industry at forefront of battle against COVID-19: Sun Pharma chairman
"Sun Pharma has ensured adequate supplies of medicines to its customers across the world despite the supply chain disruptions and the lockdown restrictions in various countries," he added. Changes at manufacturing facilities have been made to ensure productivity, as well as adherence to all safety and hygiene protocols. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 26, 2020 Category: Pharmaceuticals Source Type: news

Alembic Pharmaceuticals gets USFDA's tentative approval for type 2 diabetes drug
The tentatively approved abbreviated new drug application (ANDA) is therapeutically equivalent to the reference listed drug product Glyxambi tablets, 10 mg/5 mg and 25 mg/5 mg, of Boehringer Ingelheim Pharmaceuticals, Inc. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 26, 2020 Category: Pharmaceuticals Source Type: news

Novartis Technical Operations to hire more in India: Amit Nastik
"We are looking at hiring in Hyderabad, Novartis Knowledge City (NKC). Hyderabad being the 6th largest city in India for the talent market space, has been able to attract with its open and welcoming culture talents, including global citizens who are interested to return to India," said Amit Nastik. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 25, 2020 Category: Pharmaceuticals Source Type: news

Indian researchers start trials on saliva-based Covid-19 testing
The Medanta Institute of Education and Research in Gurgaon, Mumbai-based diagnostics company TransAsia Bio and Pune ’s Mylab are among those trying to get this testing method validated by demonstrating that analysis of saliva samples is as accurate as nasopharyngeal swab collection. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 25, 2020 Category: Pharmaceuticals Source Type: news

Indian scientists find N95 masks to be most effective at stopping COVID-19 spread
The researchers noted that airborne transmission by respiratory aerosol droplets produced during coughing and sneezing is the dominant mode of spreading for infectious diseases such as COVID-19. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 25, 2020 Category: Pharmaceuticals Source Type: news

Lupin gets US health regulator's approval for asthmatic symptoms prevention drug
The approved product is a generic version of ProAir HFA of Teva Branded Pharmaceutical Products R&D, Inc. In a regulatory filing, Lupin said it has received approval from the United States Food and Drug Administration (USFDA) for its Albuterol Sulfate Inhalation Aerosol, 90 mcg (base)/actuation. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 24, 2020 Category: Pharmaceuticals Source Type: news

Dr Reddy's forays into hospital nutrition segment with Celevida Maxx in India
It is a unique addition to Dr Reddys nutrition portfolio and is designed to help manage the nutritional needs of Cancer, Critical Care and Chronic Obstructive Pulmonary Disease (COPD) patients in India, a press release from the company said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 24, 2020 Category: Pharmaceuticals Source Type: news

Sun Pharma arm resolves product promotion investigation with US justice department
"DUSA fully cooperated with DOJ in its investigation of a complaint filed by a former employee in September 2016, ” Sun Pharmaceutical Industries said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 24, 2020 Category: Pharmaceuticals Source Type: news

Biopharma giant AstraZeneca begins coronavirus dual-use antibody drug trial in UK
The drug known as AZD7442 has the potential to be given as a preventative option for people exposed to the coronavirus, and to treat and prevent disease progression in patients already infected by the deadly virus. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 24, 2020 Category: Pharmaceuticals Source Type: news

Russia seeks collaboration with India for manufacturing Covid vaccine Sputnik V: Report
Sputnik V has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology along with Russian Direct Investment Fund (RDIF). The vaccine has not been tested in phase 3 or larger clinical trials. There has been scepticism in some quarters about limited data related to the efficacy of the vaccine. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 24, 2020 Category: Pharmaceuticals Source Type: news

Scarcity of labs may slow down vaccine trials
A scarcity of laboratories equipped to handle necessary tests and meet all safety requirements may delay trials of potential Covid-19 vaccines in India, some vaccine developers said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 24, 2020 Category: Pharmaceuticals Source Type: news

Panel to guide selection of vaccines holds 1st meet, discusses broad parameters
The experts discussed the current status of Covid-19 vaccine development in India, said an official. The group will identify gaps that may arise during the development cycle or at the implementation stage. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 24, 2020 Category: Pharmaceuticals Source Type: news

Russia, expecting plaudits for vaccine, is miffed by its cool reception
All major powers are racing to develop and produce a vaccine that, if successful and accepted by their own citizens and other countries, will earn geopolitical and economic benefits, along with prestige. The US has poured billions of dollars into an effort called Operation Warp Speed. Currently, eight vaccines are further along than Russia ’s in late-stage trials. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 23, 2020 Category: Pharmaceuticals Source Type: news

4 years on, promised mandatory pharma ethics code elusive
The code aims to end unethical practices like companies bribing doctors in cash or kind to prescribe their medicines. On Friday, the secretary held a meeting with industry associations. The minutes of the last meeting on February 17 recorded that he "showed his displeasure at the status of implementation of UCPMP". None of these meetings included civil society groups representing patient interests. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 23, 2020 Category: Pharmaceuticals Source Type: news

Pharma cos to lose pandemic-induced pricing power in Q2 as economies reopen: Report
The pharma companies cumulatively saw their pre-tax margins rising by 306 basis points (bps) on an annualised basis and 551 bps sequentially in the first quarter. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 23, 2020 Category: Pharmaceuticals Source Type: news

India conducts nearly 3.6 cr COVID-19 tests, tests per million scale new peak of 26,016
The number of people recuperating from COVID-19 has crossed 23 lakh pushing the recovery rate to over 75 per cent, while the case fatality rate, maintaining a steady downward trajectory, has further dropped to 1.85 per cent. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 23, 2020 Category: Pharmaceuticals Source Type: news

Focused on sustaining operational, financial performance in near-term: Jubilant Life Sciences
The company posted a total revenue from operations of Rs 9,154.4 crore in FY20, up 0.5 per cent year-on-year, with international revenue of Rs 7,124 crore contributing 78 per cent to the total revenue, its annual report for fiscal year 2019-20 said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 22, 2020 Category: Pharmaceuticals Source Type: news

US FDA-approved ointment found to treat, kill viral infections including Covid-19
Scientists associated with the project said the FDA-registered non-prescription over the counter (OTC) ointment has been proven to prevent, treat and kill viral infections including coronavirus. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 21, 2020 Category: Pharmaceuticals Source Type: news

Covid-19 saliva diagnosis cheaper, faster alternative to swab testing, say scientists
Giving a thumbs up to the alternative testing technology that is yet to be introduced in India, scientists said it would deliver results faster and more accurately and also minimise the risk for healthcare workers collecting samples. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 21, 2020 Category: Pharmaceuticals Source Type: news

Lupin recalls around 5.61 lakh pouches of birth control pills in the US market
The product is used to prevent pregnancy. It is manufactured in India and then supplied in the US market by Lupin Pharmaceuticals Inc, the report said. One pouch of Mibelas 24 Fe contains 28 chewable tablets. The reason for the recall is "failed impurities specifications: Out of specification result observed in related substance test", the USFDA said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 20, 2020 Category: Pharmaceuticals Source Type: news

Govt eyes 50 lakh doses of Covid vaccine in 1st order for front-line workers, army personnel and certain other categories
The prioritisation of the vaccine once it passes regulatory requirements and becomes available has been under discussion in government along with planning supply chains and distribution. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 20, 2020 Category: Pharmaceuticals Source Type: news

Strides Pharma gets USFDA nod for Ursodiol tablets, a liver disease treatment drug
Strides Pharma Science gets an approval from the USFDA to market Ursodiol tablets used for treating primary biliary cirrhosis, a progressive disease of the liver caused by a buildup of bile within the liver. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 20, 2020 Category: Pharmaceuticals Source Type: news

US hands over 100 ventilators more to India
The first shipment of 100 ventilators reached India on June 14. The ventilators were deployed to support the care of Covid-19 patients at the eight regional All India Institutes of Medical Sciences. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 19, 2020 Category: Pharmaceuticals Source Type: news

Dr Reddy's launches antiviral drug Avigan in India, to launch remdesivir in September
Indian generic drug maker Dr Reddy's Laboratories on Wednesday announced the launch of antiviral drug Avigan (favipiravir) tablets, currently being manufactured by Japanese drug giant Fujifilm Toyama Chemical Co, for potential treatment of mild to moderate Covid-19. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 18, 2020 Category: Pharmaceuticals Source Type: news

Netmeds to complement RIL's digital consultation, diagnostic test offering, say analysts
Over the past three years, RIL has announced USD 3.1 billion in acquisitions with 13 per cent in retail, 80 per cent in telecom, media and technology, and 6 per cent in energy. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 18, 2020 Category: Pharmaceuticals Source Type: news

Serum Institute looking for a $1 billion shot to fight covid, talks on with Blackstone, KKR and others
​​The company, privately owned by Cyrus Poonawalla and his son Adar Poonawalla, plans to float a special purpose vehicle (SPV) for its vaccine candidates, ET has learnt. The amount raised would go to this entity and not to SII. The company expects to close the fundraising by September. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 17, 2020 Category: Pharmaceuticals Source Type: news

Safety, efficacy main concerns with Russia's COVID-19 vaccine: Nobel laureate Peter Doherty
Sputnik V has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology along with the Russian Direct Investment Fund (RDIF). The vaccine has not been tested in Phase 3 or larger clinical trials. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 16, 2020 Category: Pharmaceuticals Source Type: news

Biological E acquires Akorn India to ramp up vaccine & injectable medicine capacities
Akorn India, a subsidiary of the US-based Akorn Inc., has a manufacturing plant of 39,000 square metres over a 14-acre campus in Himachal Pradesh with an annual capacity for about 135 million units. BE said the Akorn India facility has the potential for immediate expansion of a further 30 million units. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 16, 2020 Category: Pharmaceuticals Source Type: news

Medical stores industry body calls Amazon ’s entry to e-pharmacy “illegal”
“E-pharmacies are illegal and not recognised by the laws under the Drug& Cosmetics Act. The rules also say sale of certain drugs need to be accompanied by prescriptions, ” the letter claimed. It alleged that the government allowed home delivery of medicines during the Covid pandemic for neighbourhood pharmacies. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 16, 2020 Category: Pharmaceuticals Source Type: news

India-Dutch collaborative startup Leven Medical unveils smart ventilators with AI, ML
These ventilators, supported by a tracking software, can not only auto adjust oxygen flow of a patient but can also send alerts to the doctors/nurses and alerts to family members in case of an emergency, allow remote monitoring while the doctor is away from the hospital, claims the startup. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 16, 2020 Category: Pharmaceuticals Source Type: news